Story · Medicine & Biotech · Mind & Brain

Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial

1 outlet · first reported by Nature Medicine 9d ago

Coverage, in order

  1. 9d ago
    Nature Medicine indie study randomized trialpeer-reviewed
    Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial

    Nature Medicine, Published online: 03 November 2026; doi:10.1038/s41591-026-04786-9 Author Correction: In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.